Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ebola
Pharma
Merck eyes COVID antiviral Lagevrio amid Ebola outbreak
Merck & Co. is considering dusting off its antiviral molnupiravir, previously authorized as a COVID-19 treatment, to meet the current Ebola outbreak.
Fraiser Kansteiner
Jun 2, 2026 10:40am
CEPI funds $30M Ebola vaccine collab with Merck, SK and others
Jan 22, 2026 11:16am
Merck's Ebola vaccine proved effective in 2018 outbreak: study
Aug 22, 2024 7:50am
Emergent CEO Kramer retires, adviser steps in as interim CEO
Jun 27, 2023 3:55pm
Emergent to produce Ebola drug Ebanga in U.S. for Ridgeback
Jul 8, 2022 10:22am
With report, Gilead's slumping COVID-19 drug takes another hit
Sep 17, 2021 11:44am
